Conmed Corporation

CNMD Small Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$34.79

-2.08% today

52W: $33.21 – $61.08

52W Low: $33.21 Position: 5.7% 52W High: $61.08

🔗 Compare Brokers

Key Metrics

P/E Ratio

23.04x

Price-to-Earnings

Forward P/E

7.06x

Forward Price/Earnings

P/S Ratio

0.78x

Price-to-Sales

EV/EBITDA

9.52x

Enterprise Value/EBITDA

Div. Yield

230%

Annual dividend yield

Market Cap

$1.1B

Market Capitalization

Revenue Growth

7.9%

YoY Revenue Growth

Profit Margin

3.42%

Net profit margin

ROE

4.71%

Return on Equity

Beta

0.99

Market sensitivity

Short Interest

9.99%

% of float sold short

Avg. Volume

544,057

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

5 analysts

Avg. Price Target

$44.20

+27.05% upside

Target Range

$39.00 – $52.00

About the Company

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillo

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 3,900 Exchange: NYQ